Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78,365,632
-
Total 13F shares
-
54,593,396
-
Share change
-
+852,634
-
Total reported value
-
$1,267,069,422
-
Put/Call ratio
-
151%
-
Price per share
-
$23.22
-
Number of holders
-
139
-
Value change
-
+$26,630,495
-
Number of buys
-
65
-
Number of sells
-
76
Institutional Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q2 2023
As of 30 Jun 2023,
Replimune Group, Inc. - COMMON STOCK (REPL) was held by
139 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,593,396 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, Redmile Group, LLC, BlackRock Inc., Omega Fund Management, LLC, VANGUARD GROUP INC, BVF INC/IL, Atlas Venture Life Science Advisors, LLC, STATE STREET CORP, and Camber Capital Management LP.
This page lists
139
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.